World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
56
Citations
8602
World Ranking
2229
National Ranking
1103

Angie Rizzino publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Angie Rizzino sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 144 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Angie Rizzino D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Angie Rizzino sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 56 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Angie Rizzino is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily focuses on biochemistry, genetics, and molecular biology, with additional expertise in medicine. The scientist's work significantly engages subfields including molecular biology, oncology, pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and genetics.

Rizzino's publications span a range of topics, with notable concentration in protein degradation and inhibitors, histone deacetylase inhibitors research, prostate cancer treatment and research, radiopharmaceutical chemistry and applications, peptidase inhibition and analysis, glioma diagnosis and treatment, and hedgehog signaling pathway studies.

Frequent co-authors collaborators include Phillip J. Wilder, Ethan P. Metz, Donald W. Coulter, Sutapa Ray, and Nagendra K. Chaturvedi.

Publication venues where Rizzino's research appears most often include:

  • Cancers
  • Cancer Research
  • Pharmaceuticals
  • Diagnostics
  • BMC Cancer

Recent papers authored or co-authored by Rizzino include:

  • Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment, 2021, Diagnostics
  • The Current Therapeutic Landscape for Metastatic Prostate Cancer, 2024, Pharmaceuticals
  • Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth, 2020, BMC Cancer
  • Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells, 2022, Cancers
  • STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo, 2023, Cancers

Best Publications

  • [6] The growth of cells in serum-free hormone-supplemented media

    Jane Bottenstein;Izumi Hayashi;Sharon Hutchings;Hideo Masui

  • Small Increases in the Level of Sox2 Trigger the Differentiation of Mouse Embryonic Stem Cells

    Janel L. Kopp;Janel L. Kopp;Briana D. Ormsbee;Michelle Desler;A Angie Rizzino;A Angie Rizzino

  • Transforming growth factor-β: Multiple effects on cell differentiation and extracellular matrices

    A Angie Rizzino

  • Postnatal Developmental Delay and Supersensitivity to Organophosphate in Gene-Targeted Mice Lacking Acetylcholinesterase

    Weihua Xie;Judith A. Stribley;Arnaud Chatonnet;Phillip J. Wilder

  • The dark side of SOX2: cancer - a comprehensive overview

    Erin L. Wuebben;Angie Rizzino

  • ROCK Inhibition Enhances the Recovery and Growth of Cryopreserved Human Embryonic Stem Cells and Human Induced Pluripotent Stem Cells

    David A. Claassen;Michelle M. Desler;Angie Rizzino

  • Emerging Roles of microRNAs in the Control of Embryonic Stem Cells and the Generation of Induced Pluripotent Stem Cells

    Sunil K. Mallanna;A Angie Rizzino;A Angie Rizzino

  • Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells.

    Angie Rizzino

  • DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells

    David Lee Kelly;A Angie Rizzino

  • Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.

    Dev Karan;David Lee Kelly;A Angie Rizzino;Ming-Fong Lin

  • Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny

    Phillip J. Wilder;David Kelly;Kristen Brigman;Cynthia L. Peterson

  • Regulatory Effects of Cell Density on the Binding of Transforming Growth Factor β, Epidermal Growth Factor, Platelet-derived Growth Factor, and Fibroblast Growth Factor

    A Angie Rizzino;Peter Kazakoff;Eric Ruff;Charles Kuszynski

  • Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes

    Brian Boer;Janel Kopp;Sunil Mallanna;Michelle Desler

  • Concise review: The Sox2-Oct4 connection: critical players in a much larger interdependent network integrated at multiple levels.

    A Angie Rizzino

  • The Transcription Factor Encyclopedia

    Dimas Yusuf;Stefanie L. Butland;Magdalena I. Swanson;Eugene I. Bolotin

  • Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis

    Angie Rizzino;Erin L. Wuebben

  • SPECIFIC DOWN-REGULATION OF ANNEXIN II EXPRESSION IN HUMAN CELLS INTERFERES WITH CELL PROLIFERATION

    Yungping Chiang;A Angie Rizzino;Zita A. Sibenaller;Marc S. Wold

  • The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

    Jesse L. Cox;Phillip J. Wilder;Joshua M. Gilmore;Joshua M. Gilmore;Erin L. Wuebben

  • Proteomic Analysis of Sox2-Associated Proteins During Early Stages of Mouse Embryonic Stem Cell Differentiation Identifies Sox21 as a Novel Regulator of Stem Cell Fate

    Sunil K. Mallanna;Briana D. Ormsbee;Michelina Iacovino;Joshua M. Gilmore

  • Production of PDGF-like growth factors by embryonal carcinoma cells and binding of PDGF to their endoderm-like differentiated cells

    Angie Rizzino;Daniel F. Bowen-Pope

Frequent Co-Authors

Peggy J. Farnham
Peggy J. Farnham University of Southern California
Sylvie Mader
Sylvie Mader University of Montreal
Kathleen J. Millen
Kathleen J. Millen Seattle Children's Hospital
Robert F. Hevner
Robert F. Hevner University of California, San Diego
Paola Bovolenta
Paola Bovolenta Spanish National Research Council
Bruce E. Torbett
Bruce E. Torbett Seattle Children's Hospital
Elizabeth M. Simpson
Elizabeth M. Simpson University of British Columbia
Wyeth W. Wasserman
Wyeth W. Wasserman University of British Columbia
Reiner A. Veitia
Reiner A. Veitia Université Paris Cité
Alison H. Banham
Alison H. Banham University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Molecular Biology, there are several related online degree programs and career pathways that may align with your interests, especially in healthcare and nursing. For those looking to advance quickly, fast track nurse practitioner programs offer an accelerated pathway to becoming a licensed nurse practitioner, often in less time than traditional routes.

Many professionals start as registered nurses before advancing their careers. Options like the rn to bsn online programs allow you to complete your Bachelor of Science in Nursing in as little as six months. If you have an Associate Degree in Nursing, you might consider adn to np programs to bridge directly to a Master’s degree and nurse practitioner qualifications.

As you evaluate these pathways, it’s important to understand future earning potential. Advanced roles such as psychiatric nurse practitioners can be especially rewarding. See the average pmhnp salary by state to help guide your decision.

Best Scientists Citing Angie Rizzino

Trending Scientists

Recently Published Articles